A 39-year-old, overweight (BMI 27 kg/m2) patient comes into your office for his annual wellness examination. Routine labs show random plasma glucose of 176 mg/dL, so you ask him to return for a fasting plasma glucose and A1C. The results show a FPG 139 mg/dL and A1C of 7.7%. He is resistant to the idea of starting medication and is very keen on pursuing a trial period of dietary modifications and an exercise program, especially after you tell him about the benefits of moderate exercise on diabetes. Which of the following statements about exercise is true? A. Exercise reduces basal insulin levels only when paired with proper diet B. Exercise can lead to weight loss, but rarely reduces A1C levels C. Exercise can reduce all-cause mortality by up to 38% D. Exercise must be rigorous and regular to lead to greatest reduction in mortality Follow the link for the answer.

Would you consider using a diabetes software program that can determine the best treatment for type 2 and provide you 3 possible solutions that fit into the patient’s budget using their insurance? Follow the link to see how you and your colleagues compare.

Robert Rapaport, MD is Professor of Pediatrics, Chief of the Division of Pediatric Endocrinology and Diabetes and the Emma Elizabeth Sullivan Professor of Pediatric Endocrinology and Diabetes at Icahn School of Medicine at Mount Sinai, New York. He directs an annual Pediatric Endocrinology/Diabetes Symposium. He has been a long time active member of the Pediatric Endocrine Society serving in many capacities during membership. He was elected member of the American Pediatric Society.

In this Exclusive Interview transcript, Dr. Robert Rapaport discusses his work with pediatric diabetes patients and the challenges as children with diabetes outgrow pediatrics and transition to adult care.

In this Exclusive Interview, Dr. Robert Rapaport talks with Diabetes in Control Publisher Steve Freed during the AACE 2017 convention in Austin, Texas about his work with pediatric patients with diabetes and transitioning them to adult care.

In part 1 of this Exclusive Interview, Dr. Robert Rapaport talks with Diabetes in Control Publisher Steve Freed during the AACE 2017 convention in Austin, Texas about the necessity of a proper, eventual transition of pediatric patients to adult care.

In part 2 of this Exclusive Interview, Dr. Robert Rapaport talks with Diabetes in Control Publisher Steve Freed during the AACE 2017 convention in Austin, Texas about the complexities of managing diabetes, including in pediatric patients.

In part 3 of this Exclusive Interview, Dr. Robert Rapaport talks with Diabetes in Control Publisher Steve Freed during the AACE 2017 convention in Austin, Texas about the use and concern about the CGM in managing pediatric diabetes.

In part 4 of this Exclusive Interview, Dr. Robert Rapaport talks with Diabetes in Control Publisher Steve Freed during the AACE 2017 convention in Austin, Texas about the use of the latest diabetes technology in his practice.

In part 5, the conclusion of this Exclusive Interview, Dr. Robert Rapaport talks with Diabetes in Control Publisher Steve Freed during the AACE 2017 convention in Austin, Texas about what he wants healthcare practitioners to understand about transitioning pediatric patients and his goals for his patients' A1C.